06/16/2025
“Ahora están en un momento empoderado”, dice Gisela Stablun, médica y directora de Salud Sexual y Reproductiva en el gobierno de la provincia de Buenos Aires. Habla de las fuerzas que trabajan contra la legalizacion del ab**to en Argentina, a pesar de que sea un derecho ya adquirido. [English below]
“Hay una desinformaciĂłn o un intento todo el tiempo de desinformar o desestabilizar la polĂtica. Eso implica un doble esfuerzo para nosotras: poder seguir informando sobre la práctica y que los insumos necesarios lleguen”, dice, y agrega: “TambiĂ©n nos pasa que las personas llaman para preguntar si todavĂa se puede abortar.”
El ab**to es legal en Argentina, pero el acceso ha cambiado de forma sutil y no tan sutil bajo la presidencia de Javier Milei. Elegido en noviembre de 2023, el lĂder libertario ha calificado el ab**to de “homicidio agravado” y ha recortado drásticamente la financiaciĂłn del misoprostol y la mifepristona, medicamentos utilizados para realizar ab**tos. Durante el gobierno anterior, el estado compraba ambos medicamentos al por mayor y financiaba su distribuciĂłn; los fármacos se administraban gratuitamente a travĂ©s del sistema pĂşblico de salud. El gobierno de Milei ha suspendido esta distribuciĂłn, dejando la compra de medicamentos abortivos en manos de las autoridades provinciales. En las provincias con dificultades econĂłmicas o gobernadas por polĂticos que se oponen al ab**to, esto ha dejado a las mujeres con un acceso inadecuado a la atenciĂłn mĂ©dica.
Este capĂtulo forma parte del proyecto «Derechos de las mujeres en Argentina en la era de Javier Milei» de Anita Pouchard Serra y Natalie Alcoba publicado en The Dial Magazine y El Diario AR
👉 https://bit.ly/45hCB5A
------
Abortion is legal in Argentina, but access has changed in subtle and not so subtle ways under the presidency of Javier Milei. Elected in November 2023, the libertarian leader has called abortion “aggravated murder” and has slashed funding for misoprostol and mifepristone, medication used to carry out an abortion. Under the previous government, the state made bulk purchases for both and paid for their distribution; the drugs were administered free of cost through the public health care system. Milei’s government has suspended this distribution, leaving the purchase of abortion drugs in the hands of provincial authorities. In provinces that are cash-strapped, or that are run by politicians who oppose abortion, this has effectively left women with inadequate access to care.
“Some provinces have seen access to abortion services practically dismantled,” according to Carlota Ramirez, who oversees the department of gender and health equality in the province of Buenos Aires. “The national government has also banned its technical teams from holding abortion training and has even prohibited discussion of abortion in work meetings,” according to Ramirez.
A report released in December by three research groups on reproductive rights describes how several provincial governments have difficulty meeting the sexual health needs of residents, largely because they have to absorb new costs. REDAAS, the Network of Safe Abortion Access in Argentina, said there has been a “brutal decline” in financing for measures that are essential to the delivery of free abortion services through the public health care system, as is guaranteed by law. In some cases, women must buy the medication themselves, which can cost around 170,000 Argentine pesos for both drugs (roughly $160, according to the official exchange rate) or 100,000 pesos for misoprostol alone ($90).